In APP/PS1 mice, a well-known transgenic AD mice model, FNDC5 gene expression in the hippocampus showed a notable decrease compared to WT mice, and when they reached 6 months of age, APP/PS1 mice initiated the formation of amyloid plaques, experienced gliosis, and exhibited cognitive decline. Here, FNDC5 is linked to Alzheimer disease.